- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Adult ADHD Self-Report Scale.
Displaying page 1 of 1.
EudraCT Number: 2015-000488-15 | Sponsor Protocol Number: 3.0 | Start Date*: 2015-10-07 | |||||||||||
Sponsor Name:University of Leipzig | |||||||||||||
Full Title: Vigilance regulation as predictor of response to Psychostimulants in adult patients with ADHD | |||||||||||||
Medical condition: Attention deficit-hyperactivity disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002111-82 | Sponsor Protocol Number: 42603ATT3013 | Start Date*: 2007-10-24 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V., Turnhoutseweg 30, B-2340 Beerse, Belgium | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate Efficacy and Safety of Prolonged Release (PR) OROSĀ® methylphenidate (54 and 72 mg/day) i... | |||||||||||||
Medical condition: Attention Deficit-Hyperactivity Disorder (ADHD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) SE (Completed) NL (Completed) DK (Completed) FI (Completed) BE (Completed) GB (Completed) ES (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004710-95 | Sponsor Protocol Number: REPAS161118 | Start Date*: 2018-02-07 |
Sponsor Name:Beroendecentrum Stockholm | ||
Full Title: Extended-release injectable suspension naltrexone (XR-NTX) as an adjunt pharmacotherapy for prevention of substance use in patients with SUD who are currently in treatment for ADHD: A multicenter r... | ||
Medical condition: Amphetamine dependence and ADHD (Attention-Deficit/Hyperactivity Disorder) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001098-55 | Sponsor Protocol Number: MMED007 | Start Date*: 2021-11-24 |
Sponsor Name:Mind Medicine, Inc. | ||
Full Title: Safety and efficacy of repeated low dose D-lysergic acid diethylamide (LSD) D-Tartrate (MM-120) as treatment for ADHD in adults: a multi-center, randomized, double- blind, placebo-controlled Phase ... | ||
Medical condition: Attention-Deficit/Hyperactivity Disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-004037-18 | Sponsor Protocol Number: 42603ATT3004 | Start Date*: 2006-03-10 | |||||||||||
Sponsor Name:Janssen-Cilag Medical Affairs EMEA | |||||||||||||
Full Title: An Open Label, Multicentre Study to Evaluate the Long Term Safety of Prolonged Release (PR) OROS Methylphenidate (18, 36, 54, 72 and 90 mg/day) in Adults with Attention Deficit/Hyperactivity Disor... | |||||||||||||
Medical condition: Attention Deficit-Hyperactivity Disorder (ADHD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002002-20 | Sponsor Protocol Number: 2014METAL1 | Start Date*: 2015-06-10 |
Sponsor Name:UMCG | ||
Full Title: A multicentre randomized double-blind placebo controlled discontinuation trial of methylphenidate | ||
Medical condition: attention-deficit/hyperactivity disorder | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-000730-37 | Sponsor Protocol Number: 42603ATT3002 | Start Date*: 2005-02-07 | |||||||||||
Sponsor Name:Janssen-Cilag Medical Affairs EMEA | |||||||||||||
Full Title: A multicentre, randomised, double-blind, placebo-controlled, parallel group, dose-response phase III A study to evaluate safety and efficacy of Prolonged Release (PR) OROS methylphenidate (18, 36 a... | |||||||||||||
Medical condition: Attention Deficit Hyperactivity Disorder (ADHD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DK (Completed) CZ (Completed) FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-007672-41 | Sponsor Protocol Number: Protocol B4Z-MC-LYDO | Start Date*: 2008-12-23 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: Protocol B4Z-MC-LYDO(b) Maintenance of Response After Open-Label Treatment with Atomoxetine Hydrochloride in Adult Outpatients with Attention-Deficit/Hyperactivity Disorder (ADHD): A Placebo-Cont... | |||||||||||||
Medical condition: Attention-Deficit/Hyperactivity Disorder (ADHD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) NL (Completed) DE (Completed) ES (Completed) FR (Completed) PT (Completed) SE (Completed) AT (Completed) FI (Completed) BE (Completed) DK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
